For instance, the stereotyped BCR subset #2 identifies a subgroup of CLL patients who, despite carrying mutated IGHV genes, are characterized by a very poor outcome and may deserve novel therapeutic strategies [48]. Here, BCR is linked to B-cell chronic lymphocytic leukemia.